Hospira Investor Seeks Stock Appraisal Of $17B Pfizer Deal
An investment firm with a stake in Hospira asked the Delaware Chancery Court on Friday for an appraisal of their stock following the injectables and biosimilars company's $17 billion merger with...To view the full article, register now.
Already a subscriber? Click here to view full article